Cargando…
Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253702/ https://www.ncbi.nlm.nih.gov/pubmed/25505925 http://dx.doi.org/10.1155/2014/679436 |
_version_ | 1782347274977804288 |
---|---|
author | Shen, Aling Chen, Hongwei Chen, Youqin Lin, Jiumao Lin, Wei Liu, Liya Sferra, Thomas J. Peng, Jun |
author_facet | Shen, Aling Chen, Hongwei Chen, Youqin Lin, Jiumao Lin, Wei Liu, Liya Sferra, Thomas J. Peng, Jun |
author_sort | Shen, Aling |
collection | PubMed |
description | The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-β pathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-β signaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-β pathway. |
format | Online Article Text |
id | pubmed-4253702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-42537022014-12-11 Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway Shen, Aling Chen, Hongwei Chen, Youqin Lin, Jiumao Lin, Wei Liu, Liya Sferra, Thomas J. Peng, Jun Evid Based Complement Alternat Med Research Article The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-β pathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-β signaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-β pathway. Hindawi Publishing Corporation 2014 2014-11-19 /pmc/articles/PMC4253702/ /pubmed/25505925 http://dx.doi.org/10.1155/2014/679436 Text en Copyright © 2014 Aling Shen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Shen, Aling Chen, Hongwei Chen, Youqin Lin, Jiumao Lin, Wei Liu, Liya Sferra, Thomas J. Peng, Jun Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title | Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title_full | Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title_fullStr | Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title_full_unstemmed | Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title_short | Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway |
title_sort | pien tze huang overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal carcinoma cells via suppression of tgf-β pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253702/ https://www.ncbi.nlm.nih.gov/pubmed/25505925 http://dx.doi.org/10.1155/2014/679436 |
work_keys_str_mv | AT shenaling pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT chenhongwei pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT chenyouqin pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT linjiumao pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT linwei pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT liuliya pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT sferrathomasj pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway AT pengjun pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway |